Follow
Jon Duke
Jon Duke
Verified email at gatech.edu
Title
Cited by
Cited by
Year
Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers
G Hripcsak, JD Duke, NH Shah, CG Reich, V Huser, MJ Schuemie, ...
MEDINFO 2015: eHealth-enabled Health, 574-578, 2015
8632015
Generating multi-label discrete patient records using generative adversarial networks
E Choi, S Biswal, B Malin, J Duke, WF Stewart, J Sun
Machine learning for healthcare conference, 286-305, 2017
4862017
Explainable prediction of medical codes from clinical text
J Mullenbach, S Wiegreffe, J Duke, J Sun, J Eisenstein
arXiv preprint arXiv:1802.05695, 2018
4342018
Characterizing treatment pathways at scale using the OHDSI network
G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ...
Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016
2892016
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
MA Suchard, MJ Schuemie, HM Krumholz, SC You, RJ Chen, N Pratt, ...
The Lancet 394 (10211), 1816-1826, 2019
2072019
Defining a reference set to support methodological research in drug safety
PB Ryan, MJ Schuemie, E Welebob, J Duke, S Valentine, AG Hartzema
Drug safety 36, 33-47, 2013
1232013
Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions
JD Duke, X Han, Z Wang, A Subhadarshini, SD Karnik, X Li, SD Hall, ...
Public Library of Science 8 (8), e1002614, 2012
1182012
Adherence to drug—drug interaction alerts in high-risk patients: a trial of context-enhanced alerting
JD Duke, X Li, P Dexter
Journal of the American Medical Informatics Association 20 (3), 494-498, 2013
712013
Supporting clinical cognition: a human-centered approach to a novel ICU information visualization dashboard
A Faiola, P Srinivas, J Duke
AMIA Annual Symposium Proceedings 2015, 560, 2015
572015
A quantitative analysis of adverse events and “overwarning” in drug labeling
J Duke, J Friedlin, P Ryan
Archives of internal medicine 171 (10), 941-954, 2011
572011
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest
RD Boyce, PB Ryan, GN Norén, MJ Schuemie, C Reich, J Duke, ...
Drug safety 37, 557-567, 2014
532014
Development and preliminary evidence for the validity of an instrument assessing implementation of human-factors principles in medication-related decision-support systems—I-MeDeSA
M Zachariah, S Phansalkar, HM Seidling, PM Neri, KM Cresswell, J Duke, ...
Journal of the American Medical Informatics Association 18 (Supplement_1 …, 2011
532011
A successful model and visual design for creating context-aware drug-drug interaction alerts
JD Duke, D Bolchini
AMIA Annual Symposium Proceedings 2011, 339, 2011
512011
ADESSA: a real-time decision support service for delivery of semantically coded adverse drug event data
JD Duke, J Friedlin
AMIA Annual symposium proceedings 2010, 177, 2010
512010
Multisite evaluation of a data quality tool for patient-level clinical data sets
V Huser, FJ DeFalco, M Schuemie, PB Ryan, N Shang, M Velez, RW Park, ...
482016
Data visualization speeds review of potential adverse drug events in patients on multiple medications
JD Duke, X Li, SJ Grannis
Journal of biomedical informatics 43 (2), 326-331, 2010
452010
Regenstrief Institute's Medical Gopher: a next-generation homegrown electronic medical record system
JD Duke, J Morea, B Mamlin, DK Martin, L Simonaitis, BY Takesue, ...
International journal of medical informatics 83 (3), 170-179, 2014
412014
Consistency in the safety labeling of bioequivalent medications
J Duke, J Friedlin, X Li
Pharmacoepidemiology and drug safety 22 (3), 294-301, 2013
412013
Risk of angioedema associated with levetiracetam compared with phenytoin: findings of the observational health data sciences and informatics research network
JD Duke, PB Ryan, MA Suchard, G Hripcsak, P Jin, C Reich, MS Schwalm, ...
Epilepsia 58 (8), e101-e106, 2017
402017
Comparative first-line effectiveness and safety of ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study
RJ Chen, MA Suchard, HM Krumholz, MJ Schuemie, S Shea, J Duke, ...
Hypertension 78 (3), 591-603, 2021
342021
The system can't perform the operation now. Try again later.
Articles 1–20